Georg Behrens, MD, PhD, highlights superior virological suppression and immune recovery with bictegravir-based therapy in therapy-naïve individuals with advanced HIV disease.
Georg Behrens, MD, PhD
Advertisement
Professor for T-cell Immunology in the Department of Rheumatology and Immunology at Hannover Medical School, Hannover, Germany.
Articles by Georg Behrens, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
2
Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals
3
FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in Australia
4
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
5
